Literature DB >> 25698391

Health and quality of life in patients with primary and secondary lymphedema of the lower extremity.

Kai Huggenberger1, Stephan Wagner2, Susanne Lehmann1, André Aeschlimann3, Beatrice Amann-Vesti4, Felix Angst1.   

Abstract

BACKGROUND: Little is known about comprehensively measured health and quality of life of lower limb lymphedema (LLL). The aim of this study was to determine health and quality of life of LLL patients stratified by primary and secondary lymphedema compared to a normative population-based data stratified by age, sex and comorbidity. PATIENTS AND METHODS: A cross-sectional study of patients after treatment at the department of angiology of a rehabilitation clinic was conducted. Self-assessment was performed by the Short Form 36 (SF-36) and two condition-specific measures.
RESULTS: Primary LLL (n = 52) 75 % female, mean age 47.1 years) reported health comparable to normative values, e. g. SF-36 physical functioning 80.4 (norm 84.1, p = 0.512) and SF-36 vitality 62.7 (59.7, p = 0.117) (mean scores, 100 = best). Secondary LLL (n = 60, 68 % female, mean age 60.6 years) scored 68.1 (73.9, p = 0.049) and 55.2 (56.2, p = 0.800) on the corresponding scales. Mean symptoms and function scores on the specific measures ranged from 70.0 to 83.1 for primary LLL (100 = best) and from 63.3 to 80.6 for secondary LLL. Function, vitality and both SF-36 role dimensions were higher in primary LLL than in secondary LLL, (mean SF-36 vitality 62.7 versus 55.2, p = 0.035).
CONCLUSIONS: Overall health and quality of life was high and comparable to the general population norms in primary LLL. The same was true for most psycho-social scales in secondary LLL whereas functionally some deficits were recorded. Cancer as the most frequent cause for secondary LLL may affect health in these dimensions. Reported negative effects of LLL seem to be well compensated, especially in primary LLL and under optimal treatment.

Entities:  

Keywords:  Lymphedema; SF-36; lower extremity; quality of life; rehabilitation

Mesh:

Year:  2015        PMID: 25698391     DOI: 10.1024/0301-1526/a000419

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  4 in total

Review 1.  [Complex decongestive therapy].

Authors:  B Heinig; U Wollina
Journal:  Hautarzt       Date:  2015-11       Impact factor: 0.751

2.  A Comparison of the Quality of Life in Patients With Primary and Secondary Lower Limb Lymphedema: A Mixed-Methods Study.

Authors:  Deonni P Stolldorf; Mary S Dietrich; Sheila H Ridner
Journal:  West J Nurs Res       Date:  2016-05-05       Impact factor: 1.967

3.  Symptom Frequency, Intensity, and Distress in Patients with Lower Limb Lymphedema.

Authors:  Deonni P Stolldorf; Mary S Dietrich; Sheila H Ridner
Journal:  Lymphat Res Biol       Date:  2016-01-29       Impact factor: 2.589

4.  Mobilization of Fluids in the Intensive Treatment of Primary and Secondary Lymphedemas.

Authors:  Jose Maria Pereira de Godoy; Henrique Jose Pereira de Godoy; Thatiany Gracino de Marqui; Luis Cesar Spessoto; Maria de Fatima Guerreiro Godoy
Journal:  ScientificWorldJournal       Date:  2018-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.